Association Between Atrial Fibrillation and Atherosclerosis in Patients with Acute Lower Limb Arterial Ischemia: A

Xi Zhao1,2, Yang Jin3, Fei Shao1,2

  • 1School of Clinical Medicine, Jining Medical University, Jining, Shandong, China.

Insights

This study found atrial fibrillation (AF) is linked to reduced atherosclerosis risk in acute lower limb ischemia (ALLI) patients. Further research is needed to confirm this unexpected finding and explore its mechanisms.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Surgery
  • Radiology

Background:

  • The relationship between atrial fibrillation (AF) and atherosclerosis is not well understood.
  • Atherosclerosis is a key factor in acute lower limb ischemia (ALLI).

Purpose of the Study:

  • To investigate the correlation between AF and atherosclerosis risk in patients diagnosed with ALLI.

Main Methods:

  • A retrospective cohort study of 175 ALLI patients who underwent CT angiography (CTA).
  • Data collected included demographics, risk factors, ischemic locations, and CTA findings.
  • Statistical analyses explored the association between AF and atherosclerosis.
  • Rutherford and TASC II classifications were used to assess disease severity.

Main Results:

  • Atrial fibrillation (AF) was identified in 26.3% of ALLI patients.
  • Multiple logistic regression revealed a significant negative correlation between AF and both aorto-iliac and femoral-popliteal atherosclerosis.
  • Patients with AF showed a decreased prevalence of atherosclerosis in these arterial segments.

Conclusions:

  • This study suggests an inverse relationship between AF and atherosclerosis in ALLI patients.
  • The findings challenge current understanding and necessitate further investigation.
  • Prospective studies are required to validate these results and elucidate underlying mechanisms.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
41
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
35
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
59
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
41
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
38
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
92